Astrazeneca Ab v. Apotex Corp.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• distinguishing reasonable royalty analysis from lost-profits analysis, which focuses on the patentee’s selling price and lost sales
• patented third-party formulations were not “available” to infringer for royalty analysis without proof by infringer it could use them, rejecting infringer’s conclusory assertions
• noting Georgia-Pacific factors are “frequently cited” for reasonable royalty analyses

Source: CourtListener parenthetical corpus (CC0).